Enriching phase I trials with molecular alterations: Interim analysis of 708 patients enrolled in the MOSCATO 01

Date 02 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Phase 1 studies: Miscellaneous drugs & targets
Topics Anti-Cancer Agents & Biologic Therapy
Personalised Medicine
Presenter Christophe Massard